Cellectis S.A. CLLS
1.47
0.04
2.80%
as of 25 Sep
- Market cap
- $103.4M
- P/E
- 0.0×
Follow CLLS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(30.75%) | (65.33%) | (76.34%) | (94.54%) | |
| (9.57%) | (19.09%) | (20.58%) | (21.02%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(31.06%) | (52.28%) | (62.57%) | (77.52%) | |
Average Days of Receivables |
108.18 | 101.80 | 61.93 | 72.06 | |
Free Cash Flow per Share |
(0.34) | (0.44) | (0.40) | (0.44) | |
Free Cash Flow |
(33.90) | (44.16) | (39.88) | (43.80) | |
Capital Expenditures |
(4.82) | (4.76) | (2.23) | (2.18) | |
Piotroski F-Score |
3.00 | 2.00 | 2.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(7.77%) | (10.68%) | (11.69%) | (14.78%) | |
Accounts Receivable Turnover |
3.22 | 3.67 | 4.20 | 3.38 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | (0.01) | 0.00 | |
Research and Development Expense of Revenue |
108.96% | 117.50% | 131.50% | 157.73% | |
Selling, General and Administrative Expense of Revenue |
24.13% | 24.86% | 27.53% | 33.44% | |
Share Based Compensation of Revenue |
5.75% | 7.68% | 9.05% | 12.23% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.82 | 0.58 | 0.56 | 0.64 | |
Depreciation/Fixed assets |
0.50 | 0.52 | 0.53 | 0.55 | |
Capex/Depreciation |
(0.23) | (0.24) | (0.11) | (0.11) | |
Revenue per Share |
0.82 | 0.79 | 0.75 | 0.63 | |
Operating CF per Share |
(0.29) | (0.39) | (0.37) | (0.41) | |
Capex per Share |
(0.05) | (0.05) | (0.02) | (0.02) | |
Capex to Sales |
0.06 | 0.06 | 0.03 | 0.03 | |
Net Profit Margin |
(42.83%) | (84.92%) | (89.51%) | (102.34%) |
Columns are period end dates